Latest data from September 24, 2021
Number of Health Center respondents = 12 (60% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 | 3,922 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) | 70.36% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 | 425 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) | 59.71% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, antigen)2 | Patients Tested Positive, Virus Detection (PCR, antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 29.04% | 39.06% |
| White, Hispanic/Latino Patients | 0.71% | 0.71% |
| Black/African American, Non-Hispanic/Latino Patients | 62.37% | 50.82% |
| Black/African American, Hispanic/Latino Patients | 0.13% | 0.00% |
| Asian Patients3 | 0.36% | 0.00% |
| American Indian/Alaska Native Patients3 | 0.61% | 0.47% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.94% | 2.12% |
| Patients with More than one race3 | 2.19% | 1.41% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 1.63% | 2.35% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 1.66% | 2.82% |
| Unreported/Refused to Report Race and Ethnicity | 0.36% | 0.24% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 728 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 82.87% |
| COVID-19 Immunization Series Completed | 1,319 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 73.89% |
| COVID-19 Immunization Series Additional | 177 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 90.70% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 16.90% | 25.78% | 9.04% |
| White, Hispanic/Latino Patients | 0.14% | 0.61% | 0.00% |
| Black/African American, Non-Hispanic/Latino Patients | 78.57% | 68.61% | 64.41% |
| Black/African American, Hispanic/Latino Patients | 0.00% | 0.08% | 0.00% |
| Asian Patients3 | 0.27% | 1.06% | 0.00% |
| American Indian/Alaska Native Patients3 | 0.00% | 0.15% | 22.03% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.82% | 0.45% | 1.13% |
| Patients with More than one race3 | 1.24% | 0.83% | 0.56% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 0.69% | 1.14% | 0.00% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 0.96% | 0.83% | 1.13% |
| Unreported/Refused to Report Race and Ethnicity | 0.41% | 0.45% | 1.69% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 8.33% |
| 1 to 24 Hours | 41.67% |
| More Than 24 Hours | 50.00% |
| N/A | 0.00% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 16.67% |
| Staffing to administer the vaccine | 58.33% |
| Vaccine confidence | 16.67% |
| Vaccine storage capacity | 0.00% |
| Vaccine supply | 0.00% |
| Other | 8.33% |
| None | 25.00% |
Operations and Staff
| Metrics | Value |
|---|---|
| Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits | 65.83% |
| Average Percent of Health Center Visits Conducted Virtually | 12.92% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 66.67% |
| Number of Mobile Van Sites | 18 |
| Number of Pop-up Clinics | 11 |
| Number of School-Based Vaccination Sites | 1 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 25.00% |
| Refer patients to another organization that provides monoclonal antibody therapies | 25.00% |
| None | 50.00% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 0.00% |
| Patient awareness/education | 0.00% |
| Staffing capacity | 16.67% |
| Therapy administration/onsite logistics | 33.33% |
| Other | 16.67% |
| None | 50.00% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
